+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06855004

Multicenter Study of Adults With Fibrosing Interstitial Lung Disease in Intensive Care for Acute Respiratory Failure

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-03-03

250

Participants Needed

1

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying patients with fibrosing interstitial lung diseases ILD who are admitted to intensive care units ICUs for acute respiratory failure ARF. ILD includes various disorders that cause progressive scarring and inflammation in the lungs, often leading to chronic breathing problems. Acute respiratory failure in these patients is a serious complication caused by infections, blood clots in the lungs, heart problems, or sudden worsening of fibrosis. The study aims to better understand survival rates and outcomes in this group, as current ICU care is challenging and lacks strong evidence-based guidance. The study is observational and involves multiple centers. It follows patients admitted to ICUs who require oxygen therapy, high-flow oxygen, or mechanical ventilation. The research collects data on ICU and hospital survival, use of breathing support methods like invasive and non-invasive ventilation or extracorporeal membrane oxygenation ECMO, and treatments such as kidney support or medications to support blood pressure. The study also tracks lung transplantation during hospitalization and decisions about limiting life-sustaining treatments. Quality of life and functional status are assessed six months after ICU discharge using questionnaires. Participants will be monitored from ICU admission through six months for survival, length of stay, organ support use, infections acquired in ICU, and quality of life changes. The study uses tools like the Barthel Index and SF-36 questionnaire to evaluate patients function and well-being. This comprehensive follow-up will help provide insights into long-term benefits and challenges of ICU care for ILD patients, informing future clinical decisions and improving patient-centered care.

CONDITIONS

Brief Title

Prospective Cohort of Patients With Fibrosing Interstitial Lung Disease Admitted for Acute Respiratory Failure

Research Team

N

Nathan EBSTEIN, Dr

S

Stéphane Gaudry, Pr

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here